Dr. Reddy's laboratories reports 66% rise in Q4 consolidated net profit

17 May 2019 Evaluate

Dr. Reddy's laboratories has reported results for the fourth quarter and year ended March 31, 2019. 

The company has reported a rise of 14.77% in its net profit at Rs 202.80 crore for the quarter ended March 31, 2019 as compared to Rs 176.70 crore for the same quarter in the previous year. Total income of the company increased by 5.94% at Rs 2,717.90 crore for quarter under review as compared to Rs 2,565.40 crore for the quarter ended March 31, 2018.

On consolidated basis, the company has reported rise of 65.80% in its net profit at Rs 439.70 crore for the quarter ended March 31, 2019 as compared to Rs 265.20 crore for the corresponding quarter in the FY18. Total consolidated income of the company rose 14.29% at Rs 4,112.90 crore for quarter under review as compared to Rs 3,598.80 crore for the same quarter ended previous year.

For the year ended March 31, 2019, the company has posted a 2-fold jump in its net profit at Rs 1,277.30 crore as compared to Rs 566.90 crore for the previous year. Total income of company increased 13.60% at Rs 10,863.90 crore for year under review as compared to Rs 9,563.30 crore for year ended March 31, 2018.

For the year ended March 31, 2019, on the consolidated basis, the company has posted a 2-fold jump in its net profit at Rs 1,906.20 crore as compared to Rs 912.40 crore for the previous year. Total income of company increased by 9.35% at Rs 15,785.70 crore for year under review as compared to Rs 14,436.20 crore for year ended March 31, 2018.

Dr. Reddys Lab Share Price

6263.70 46.55 (0.75%)
26-Apr-2024 16:01 View Price Chart
Peers
Company Name CMP
Sun Pharma Inds. 1504.25
Dr. Reddys Lab 6263.70
Cipla 1406.25
Zydus Lifesciences 948.20
Lupin 1615.85
View more..
© 2024 The Alchemists Ark Pvt. Ltd. All rights reserved. MoneyWorks4Me ® is a registered trademark of The Alchemists Ark Pvt.Ltd.